Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Prenol Lipids [PR] (W) --> Isoprenoids [PR01]--> C10 isoprenoids (monoterpenes) [PR0102]--> Cyclopropane and cyclobutane monoterpenoids [PR010206]
LM_IDCommon NameSystematic NameFormulaMass
LMPR0102060001Chrysanthemic acid (W)-C10H16O2168.1150
LMPR0102060002(+)-cis-chrysanthemic acid(1R,3S)-2,2-dimethyl-3-(2-methylprop-1-
en-1-yl)cyclopropanecarboxylic acid
C10H16O2168.1150
LMPR0102060003(-)-cis-chrysanthemic acid(1S,3R)-2,2-dimethyl-3-(2-methylprop-1-
en-1-yl)cyclopropanecarboxylic acid
C10H16O2168.1150
LMPR0102060004jasmolin I(1S)-2-methyl-4-oxo-3-[(2Z)-pent-2-en-
1-yl]cyclopent-2-en-1-yl (1R,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C21H30O3330.2195
LMPR0102060005jasmolin II(1S)-2-methyl-4-oxo-3-[(2Z)-pent-2-en-
1-yl]cyclopent-2-en-1-yl (1R,3R)-3-
[(1E)-3-methoxy-2-methyl-3-oxoprop-1-
en-1-yl]-2,2-
dimethylcyclopropanecarboxylate
C22H30O5374.2093
LMPR0102060006(+)-trans-(S)-allethrin(1S)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1R,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060007(+)-trans-allethrin2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1R,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060008(+)-trans-(R)-allethrin(1R)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1R,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060009(-)-trans-allethrin2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1S,3S)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060010(-)-trans-(R)-allethrin(1R)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1S,3S)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060011(-)-trans-(S)-allethrin(1S)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1S,3S)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060012(+)-cis-allethrin2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1R,3S)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060013(+)-cis-(S)-allethrin(1S)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1R,3S)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060014(+)-cis-(R)-allethrin(1R)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1R,3S)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060015(-)-cis-allethrin2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1S,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060016(-)-cis-(S)-allethrin(1S)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1S,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060017(-)-cis-(R)-allethrin(1R)-2-methyl-4-oxo-3-(prop-2-en-1-yl)
cyclopent-2-en-1-yl (1S,3R)-2,2-
dimethyl-3-(2-methylprop-1-en-1-yl)
cyclopropanecarboxylate
C19H26O3302.1882
LMPR0102060018chrysanthemyl diphosphate[2,2-dimethyl-3-(2-methylprop-1-en-1-
yl)cyclopropyl]methyl trihydrogen
diphosphate
C10H20O7P2314.0684
LMPR0102060019(R,R)-chrysanthemyl diphosphate[(1R,3R)-2,2-dimethyl-3-(2-methylprop-
1-en-1-yl)cyclopropyl]methyl
trihydrogen diphosphate
C10H20O7P2314.0684
LMPR0102060020(-)-cis-sabinol(1R,3R,5R)-4-methylidene-1-(propan-2-
yl)bicyclo[3.1.0]hexan-3-ol
C10H16O152.1201
LMPR0102060021sabinol(3R)-4-methylidene-1-(propan-2-yl)
bicyclo[3.1.0]hexan-3-ol
C10H16O152.1201
LMPR0102060022pyrethrin II (W)(1S)-2-methyl-4-oxo-3-[(2Z)-penta-2,4-
dien-1-yl]cyclopent-2-en-1-yl (1R,3R)-
3-[(1E)-3-methoxy-2-methyl-3-oxoprop-1-
en-1-yl]-2,2-
dimethylcyclopropanecarboxylate
C22H28O5372.1937
LMPR0102060023(+)-cis-sabinol(1S,3R,5S)-4-methylidene-1-(propan-2-
yl)bicyclo[3.1.0]hexan-3-ol
C10H16O152.1201
 

logo LIPID MAPS is funded by a Wellcome Trust.